manufacturers of glp 1 drugs top drug companies GLP-1 Analogues Transform Metabolic Disease Management New federal agreement lowers GLP-1
Description
Abstract Heart failure (HF) remains one of the cardiovascular diseases (CVDs) associated with a high unmet medical need due to high morbidity and mortality rates and lack of efficacious interventions
Eur J Intern Med
Zhang G, Wang Z, Yu H, Liu X
Weight loss associated with GLP-1 agonists may lead to lean mass loss, which could be concerning for developing adolescents
Starts at $1300 for a 1-month supply Price may vary based on insurance coverage Additional costs apply, including a medical review, provider support, and side effect management
J Neurodegener Dis (2013) 2013:407152
